Article Information
History
- November 8, 2020.
Article Versions
- You are currently viewing Version 1 of this article (November 8, 2020 - 02:38).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zhuoming Liu1,6,
- Laura A. VanBlargan2,6,
- Paul W. Rothlauf1,3,
- Louis-Marie Bloyet1,
- Rita E. Chen2,4,
- Spencer Stumpf1,
- Haiyan Zhao4,
- John M. Errico4,
- Elitza S. Theel5,
- Ali H. Ellebedy1,4,
- Daved H. Fremont4,
- Michael S. Diamond1,2,4,* and
- Sean P. J. Whelan1,7,*
- 1Department of Molecular Microbiology, School of Medicine, Washington University in St. Louis
- 2Department of Medicine, School of Medicine, Washington University in St. Louis
- 3Program in Virology, Harvard Medical School, Boston MA
- 4Department of Pathology & Immunology, School of Medicine, Washington University in St. Louis
- 5Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
- ↵*Correspondence: diamond{at}wusm.wustl.edu (M.S.D), spjwhelan{at}wustl.edu (S. P. J. W.)
↵6 These authors contributed equally
Posted November 08, 2020.
Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
